Rao B N, Pratt C B, Fleming I D, Dilawari R A, Green A A, Austin B A
Cancer. 1985 Mar 15;55(6):1322-6. doi: 10.1002/1097-0142(19850315)55:6<1322::aid-cncr2820550627>3.0.co;2-5.
Carcinoma of the large bowel is rare in persons under the age of 30, and generally presents with advanced stages of disease. From 1964 to 1984, 30 patients presented with nonfamilial large bowel malignancies. Seventeen patients were male, and 13 female (age range, 8-25 years). In 15 patients the primary was in the right transverse colon. In 26 patients the lesion was above the peritoneal reflection. Classification by Dukes' staging demonstrated Stage B in 3 patients, Stage C in 7 patients, and Stage D in 20 patients. Twenty-five patients had a mucinous variety of adenocarcinoma. Surgery at initial laparotomy consisted of biopsy (10 patients), palliative segmental resection (7 patients) and complete resection (13 patients; survival in each of these groups ranged from 1 to 15 months (median, 6 months), 6 to 36 months (median, 8 months) and 7 months to 14 years (median, 6 months), respectively. The only long-term survivors are three patients who had complete resection, two of whom are surviving free of disease after 5 and 15 years, respectively. Common sites of abdominal recurrence were the omentum (6 patients) and ovaries (7 patients). All patients received chemotherapy. In 16 of 24 evaluable patients, responses lasting 3 to 18 months were observed. Five patients also received radiation therapy. Follow-up of these patients included computed tomographic scans, ultrasound, and determination of carcinoembryonic antigen (CEA) levels. The CEA level in 9 of 23 patients did not correspond with the presence of either residual disease or progression of disease. Chemotherapy combined with a second-look surgical procedure in selected cases may improve the proportion of patients surviving and the duration of survival.
30岁以下人群中,大肠癌较为罕见,且通常在疾病晚期才出现症状。1964年至1984年期间,有30例患者被诊断为非家族性大肠恶性肿瘤。其中男性17例,女性13例(年龄范围为8至25岁)。15例患者的原发肿瘤位于右横结肠。26例患者的病变位于腹膜反折以上。根据Dukes分期,3例为B期,7例为C期,20例为D期。25例患者为黏液性腺癌。初次剖腹手术包括活检(10例)、姑息性节段性切除(7例)和根治性切除(13例);这些组中的患者生存时间分别为1至15个月(中位数为6个月)、6至36个月(中位数为8个月)和7个月至14年(中位数为6个月)。仅有的长期存活者是3例接受了根治性切除的患者,其中2例分别在5年和15年后无病存活。腹部复发的常见部位是大网膜(6例)和卵巢(7例)。所有患者均接受了化疗。在24例可评估的患者中,16例观察到了持续3至18个月的反应。5例患者还接受了放疗。对这些患者的随访包括计算机断层扫描、超声检查以及癌胚抗原(CEA)水平测定。23例患者中有9例的CEA水平与残留疾病或疾病进展情况不符。在部分病例中,化疗联合二次探查手术可能会提高患者的生存率和生存时间。